These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Irreversible electroporation (Nanoknife® treatment) in the field of hepatobiliary surgery: Current status and future perspectives. Kourounis G; Paul Tabet P; Moris D; Papalambros A; Felekouras E; Georgiades F; Astras G; Petrou A J BUON; 2017; 22(1):141-149. PubMed ID: 28365947 [TBL] [Abstract][Full Text] [Related]
23. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827 [TBL] [Abstract][Full Text] [Related]
24. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293 [TBL] [Abstract][Full Text] [Related]
25. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study. Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869 [TBL] [Abstract][Full Text] [Related]
26. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience. Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870 [TBL] [Abstract][Full Text] [Related]
27. Introduction to Irreversible Electroporation--Principles and Techniques. Thomson KR; Kavnoudias H; Neal RE Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541 [TBL] [Abstract][Full Text] [Related]
29. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152 [TBL] [Abstract][Full Text] [Related]
30. Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study. Barabasch A; Distelmaier M; Heil P; Krämer NA; Kuhl CK; Bruners P Invest Radiol; 2017 Jan; 52(1):23-29. PubMed ID: 27379698 [TBL] [Abstract][Full Text] [Related]
31. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report. Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC). Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140 [TBL] [Abstract][Full Text] [Related]
33. Single-needle electroporation and interstitial electrochemotherapy: in vivo safety and efficacy evaluation of a new system. Pedersoli F; Ritter A; Zimmermann M; Schulze-Hagen M; Liebl M; Dethlefsen E; von Stillfried S; Pfeffer J; Kuhl CK; Bruners P; Isfort P Eur Radiol; 2019 Nov; 29(11):6300-6308. PubMed ID: 31101968 [TBL] [Abstract][Full Text] [Related]
34. Irreversible electroporation: Beyond the limits of tumor ablation. Alonso-González R; Abadal Villayandre JM; Gálvez Gonzalez E; Álvarez Perez MJ; Méndez Alonso S; de Gregorio Ariza MA Radiologia (Engl Ed); 2024; 66(1):47-56. PubMed ID: 38365354 [TBL] [Abstract][Full Text] [Related]
35. Irreversible electroporation and sarcomas: where do we stand? Vailas M; Syllaios A; Hashemaki N; Sotiropoulou M; Schizas D; Papalampros A; Felekouras E; Pikoulis E J BUON; 2019; 24(4):1354-1359. PubMed ID: 31646777 [TBL] [Abstract][Full Text] [Related]
36. A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma. Yan L; Chen YL; Su M; Liu T; Xu K; Liang F; Gu WQ; Lu SC Chin Med J (Engl); 2016 Dec; 129(24):2920-2925. PubMed ID: 27958223 [TBL] [Abstract][Full Text] [Related]
37. Irreversible electroporation and electrochemotherapy in oncology: State of the art. Tasu JP; Tougeron D; Rols MP Diagn Interv Imaging; 2022 Nov; 103(11):499-509. PubMed ID: 36266192 [TBL] [Abstract][Full Text] [Related]
38. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820 [TBL] [Abstract][Full Text] [Related]
39. [Irreversible electroporation - a new kid on the block?]. Kosiek O; Strach K; Ricke J; Pech M Radiologe; 2012 Jan; 52(1):38-43. PubMed ID: 22249700 [TBL] [Abstract][Full Text] [Related]
40. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values. Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]